pharmula consulting limited
pharmula consulting limited Company Information
Company Number
14606520
Next Accounts
Jan 2026
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Directors
Shareholders
clare patel
haziq patel
Group Structure
View All
Contact
Registered Address
128 city road, london, EC1V 2NX
Website
-pharmula consulting limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMULA CONSULTING LIMITED at £84.4k based on a Turnover of £182k and 0.46x industry multiple (adjusted for size and gross margin).
pharmula consulting limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMULA CONSULTING LIMITED at £142.7k based on an EBITDA of £42.2k and a 3.38x industry multiple (adjusted for size and gross margin).
pharmula consulting limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMULA CONSULTING LIMITED at £70.4k based on Net Assets of £31.7k and 2.22x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharmula Consulting Limited Overview
Pharmula Consulting Limited is a live company located in london, EC1V 2NX with a Companies House number of 14606520. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in January 2023, it's largest shareholder is clare patel with a 50% stake. Pharmula Consulting Limited is a new, micro sized company, Pomanda has estimated its turnover at £182k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pharmula Consulting Limited Health Check
Pomanda's financial health check has awarded Pharmula Consulting Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
5 Weak
Size
annual sales of £182k, make it smaller than the average company (£1.8m)
- Pharmula Consulting Limited
£1.8m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Pharmula Consulting Limited
- - Industry AVG
Production
with a gross margin of 25.5%, this company has a higher cost of product (47.4%)
- Pharmula Consulting Limited
47.4% - Industry AVG
Profitability
an operating margin of 23.2% make it more profitable than the average company (5.8%)
- Pharmula Consulting Limited
5.8% - Industry AVG
Employees
with 3 employees, this is below the industry average (17)
3 - Pharmula Consulting Limited
17 - Industry AVG
Pay Structure
on an average salary of £51.1k, the company has an equivalent pay structure (£51.1k)
- Pharmula Consulting Limited
£51.1k - Industry AVG
Efficiency
resulting in sales per employee of £60.7k, this is less efficient (£119.4k)
- Pharmula Consulting Limited
£119.4k - Industry AVG
Debtor Days
it gets paid by customers after 115 days, this is later than average (55 days)
- Pharmula Consulting Limited
55 days - Industry AVG
Creditor Days
its suppliers are paid after 71 days, this is slower than average (32 days)
- Pharmula Consulting Limited
32 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Pharmula Consulting Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Pharmula Consulting Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 47.1%, this is a lower level of debt than the average (52.6%)
47.1% - Pharmula Consulting Limited
52.6% - Industry AVG
PHARMULA CONSULTING LIMITED financials
Pharmula Consulting Limited's latest turnover from April 2024 is estimated at £182 thousand and the company has net assets of £31.7 thousand. According to their latest financial statements, Pharmula Consulting Limited has 3 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2024 | |
|---|---|
| Turnover | |
| Other Income Or Grants | |
| Cost Of Sales | |
| Gross Profit | |
| Admin Expenses | |
| Operating Profit | |
| Interest Payable | |
| Interest Receivable | |
| Pre-Tax Profit | |
| Tax | |
| Profit After Tax | |
| Dividends Paid | |
| Retained Profit | |
| Employee Costs | |
| Number Of Employees | 3 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2024 | |
|---|---|
| Tangible Assets | 734 |
| Intangible Assets | 0 |
| Investments & Other | 0 |
| Debtors (Due After 1 year) | 0 |
| Total Fixed Assets | 734 |
| Stock & work in progress | 0 |
| Trade Debtors | 57,752 |
| Group Debtors | 0 |
| Misc Debtors | 1,325 |
| Cash | 0 |
| misc current assets | 0 |
| total current assets | 59,077 |
| total assets | 59,811 |
| Bank overdraft | 0 |
| Bank loan | 0 |
| Trade Creditors | 26,456 |
| Group/Directors Accounts | 0 |
| other short term finances | 0 |
| hp & lease commitments | 0 |
| other current liabilities | 0 |
| total current liabilities | 26,456 |
| loans | 0 |
| hp & lease commitments | 0 |
| Accruals and Deferred Income | 1,688 |
| other liabilities | 0 |
| provisions | 0 |
| total long term liabilities | 1,688 |
| total liabilities | 28,144 |
| net assets | 31,667 |
| total shareholders funds | 31,667 |
| Apr 2024 | |
|---|---|
| Operating Activities | |
| Operating Profit | |
| Depreciation | |
| Amortisation | |
| Tax | |
| Stock | 0 |
| Debtors | 59,077 |
| Creditors | 26,456 |
| Accruals and Deferred Income | 1,688 |
| Deferred Taxes & Provisions | 0 |
| Cash flow from operations | |
| Investing Activities | |
| capital expenditure | |
| Change in Investments | 0 |
| cash flow from investments | |
| Financing Activities | |
| Bank loans | 0 |
| Group/Directors Accounts | 0 |
| Other Short Term Loans | 0 |
| Long term loans | 0 |
| Hire Purchase and Lease Commitments | 0 |
| other long term liabilities | 0 |
| share issue | |
| interest | |
| cash flow from financing | |
| cash and cash equivalents | |
| cash | 0 |
| overdraft | 0 |
| change in cash | 0 |
pharmula consulting limited Credit Report and Business Information
Pharmula Consulting Limited Competitor Analysis
Perform a competitor analysis for pharmula consulting limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in EC1V area or any other competitors across 12 key performance metrics.
pharmula consulting limited Ownership
PHARMULA CONSULTING LIMITED group structure
Pharmula Consulting Limited has no subsidiary companies.
Ultimate parent company
PHARMULA CONSULTING LIMITED
14606520
pharmula consulting limited directors
Pharmula Consulting Limited currently has 1 director, Mr Haziq Patel serving since Jan 2023.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Haziq Patel | United Kingdom | 50 years | Jan 2023 | - | Director |
P&L
April 2024turnover
182k
0%
operating profit
42.2k
0%
gross margin
25.6%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2024net assets
31.7k
0%
total assets
59.8k
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
pharmula consulting limited company details
company number
14606520
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
January 2023
age
1
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
April 2024
previous names
N/A
accountant
-
auditor
-
address
128 city road, london, EC1V 2NX
Bank
-
Legal Advisor
-
pharmula consulting limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pharmula consulting limited.
pharmula consulting limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PHARMULA CONSULTING LIMITED. This can take several minutes, an email will notify you when this has completed.
pharmula consulting limited Companies House Filings - See Documents
| date | description | view/download |
|---|
